Please login to the form below

Not currently logged in
Email:
Password:

Chiltern appoints Roger Hunter to partnerships role

He will be tasked with developing long-term strategic partnerships

Chiltern Roger HunterUK-headquartered contract research organisation (CRO) has appointed Roger Hunter as vice president of strategic partnerships within its business development team.

He brings 25 years of pharma and biotech experience to the company and his most recent industry-side role was as VP of operations for a speciality pharmaceutical company.

Chiltern's VP of global business development Stuart McGuire said: “It gives me great pleasure to welcome Roger Hunter as Chiltern's new VP of strategic partnerships. Roger comes to us with a strong background in both commercial and development functions within pharma and biotech. He has a strong understanding of clinical development and a deep appreciation of the impact that we have on our clients.”

Roger Hunter added: “I look forward to working in close collaboration with our sponsors to develop long standing strategic partnerships with them through the delivery of innovative, quality and flexible solutions that address their key needs.” 

16th January 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics